Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Vasopressin receptor antagonists.

Greenberg A, Verbalis JG.

Kidney Int. 2006 Jun;69(12):2124-30. Epub 2006 May 3. Review.

2.

[Etiology, diagnostics and therapy of hyponatremias].

Laczi F.

Orv Hetil. 2008 Jul 20;149(29):1347-54. doi: 10.1556/OH.2008.28409. Review. Hungarian.

PMID:
18617466
3.

Vasopressin receptor antagonists in heart failure.

Hobbs RE, Tang WH.

Recent Pat Cardiovasc Drug Discov. 2006 Jun;1(2):177-84. Review.

PMID:
18232127
4.

Therapeutic potential of vasopressin receptor antagonists.

Ali F, Guglin M, Vaitkevicius P, Ghali JK.

Drugs. 2007;67(6):847-58. Review.

PMID:
17428103
5.

[Vasopressin receptor antagonists: the vaptans].

Villabona C.

Endocrinol Nutr. 2010 May;57 Suppl 2:41-52. doi: 10.1016/S1575-0922(10)70021-8. Review. Spanish.

PMID:
21130961
6.

[Vasopressin receptor antagonists and heart failure].

Haass M.

Ther Umsch. 2009 Nov;66(11):735-40. doi: 10.1024/0040-5930.66.11.735. Review. German.

PMID:
19885790
7.

Vasopressin-receptor antagonists in heart failure.

Schweiger TA, Zdanowicz MM.

Am J Health Syst Pharm. 2008 May 1;65(9):807-17. doi: 10.2146/ajhp070132. Review.

PMID:
18436727
8.

Targeting hyponatremia and hemodynamics in acute decompensated heart failure: is there a role for vasopressin antagonists?

Valania G, Singh M, Slawsky MT.

Curr Heart Fail Rep. 2011 Sep;8(3):198-205. doi: 10.1007/s11897-010-0035-3. Review.

PMID:
21046492
9.

Diagnosis and management of hyponatremia in acute illness.

Schrier RW, Bansal S.

Curr Opin Crit Care. 2008 Dec;14(6):627-34. doi: 10.1097/MCC.0b013e32830e45e3. Review.

10.

Vasopressin and vasopressin antagonists in heart failure and hyponatremia.

Farmakis D, Filippatos G, Kremastinos DT, Gheorghiade M.

Curr Heart Fail Rep. 2008 Jun;5(2):91-6. Review.

PMID:
18765079
11.

Role of vaptans in the management of hyponatremia.

Lehrich RW, Ortiz-Melo DI, Patel MB, Greenberg A.

Am J Kidney Dis. 2013 Aug;62(2):364-76. doi: 10.1053/j.ajkd.2013.01.034. Epub 2013 May 29. Review.

PMID:
23725974
12.

AVP receptor antagonists in patients with CHF.

Kumar SK, Mather PJ.

Heart Fail Rev. 2009 Jun;14(2):83-6. doi: 10.1007/s10741-008-9107-9. Epub 2008 Sep 3. Review.

PMID:
18766439
13.

Clinical review: the use of vaptans in clinical endocrinology.

Peri A.

J Clin Endocrinol Metab. 2013 Apr;98(4):1321-32. doi: 10.1210/jc.2012-4082. Epub 2013 Feb 11. Review.

PMID:
23401044
14.

AVP receptor antagonists as aquaretics: review and assessment of clinical data.

Verbalis JG.

Cleve Clin J Med. 2006 Sep;73 Suppl 3:S24-33. Review.

PMID:
16970150
15.

Treatment of hyponatremia: the role of lixivaptan.

Liamis G, Filippatos TD, Elisaf MS.

Expert Rev Clin Pharmacol. 2014 Jul;7(4):431-41. doi: 10.1586/17512433.2014.911085. Epub 2014 Apr 28. Review.

PMID:
24766294
16.

Hyponatremia in heart failure.

Farmakis D, Filippatos G, Parissis J, Kremastinos DT, Gheorghiade M.

Heart Fail Rev. 2009 Jun;14(2):59-63. doi: 10.1007/s10741-008-9109-7. Epub 2008 Aug 29. Review.

PMID:
18758941
17.

Treatment options for hyponatremia in heart failure.

Goldsmith SR.

Heart Fail Rev. 2009 Jun;14(2):65-73. doi: 10.1007/s10741-008-9110-1. Epub 2008 Sep 6. Review.

PMID:
18777208
18.
19.

Vasopressin antagonists as aquaretic agents for the treatment of hyponatremia.

Palm C, Pistrosch F, Herbrig K, Gross P.

Am J Med. 2006 Jul;119(7 Suppl 1):S87-92. Review.

PMID:
16843091
20.

Recognition and treatment of hyponatremia in acutely ill hospitalized patients.

Patel GP, Balk RA.

Clin Ther. 2007 Feb;29(2):211-29. Review.

PMID:
17472815
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk